Feng Zhang

发表

miR-181c contributes to cisplatin resistance in non-small cell lung cancer cells by targeting Wnt inhibition factor 1

Baoli Hu, Haifeng Zhang, Haitao Wei, 2017, Cancer Chemotherapy and Pharmacology.

Bevacizumab did not reduce the risk of anemia associated with chemotherapy: an up-to-date meta-analysis

Baoli Hu, Haifeng Zhang, Zuo-pei Wang, 2015, European Journal of Clinical Pharmacology.

LncRNA CCAT1/miR-130a-3p axis increases cisplatin resistance in non-small-cell lung cancer cell line by targeting SOX4

Baoli Hu, Haifeng Zhang, Haitao Wei, 2017, Cancer biology & therapy.

Novel long noncoding RNA LINC01385 promotes nasopharyngeal carcinoma proliferation via the miR-140-3p/Twist1 signaling pathway

Lu Li, Feng Zhang, 2020, Cell cycle.

Circular RNA ZFR accelerates non-small cell lung cancer progression by acting as a miR-101-3p sponge to enhance CUL4B expression

Baoli Hu, Haifeng Zhang, F. Zhang, 2019, Artificial cells, nanomedicine, and biotechnology.

LINC01518 knockdown inhibits tumorigenicity by suppression of PIK3CA/Akt pathway in oesophageal squamous cell carcinoma

Baoli Hu, Haifeng Zhang, Haitao Wei, 2019, Artificial cells, nanomedicine, and biotechnology.

Does adenomatous polyposis coli gene promoter 1A methylation increase non‐small cell lung cancer risk? A meta‐analysis

Xiaolong Wang, Baoli Hu, Feng Zhang, 2017, Thoracic cancer.

Dehydroeffusol inhibits hypoxia-induced epithelial–mesenchymal transition in non-small cell lung cancer cells through the inactivation of Wnt/β-catenin pathway

Haitao Wei, Li Li, T. Hou, 2020, Bioscience reports.

miR-181c contributes to cisplatin resistance in non-small cell lung cancer cells by targeting Wnt inhibition factor 1

Baoli Hu, Haifeng Zhang, Haitao Wei, 2017, Cancer Chemotherapy and Pharmacology.